Journal
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL
Volume 7, Issue -, Pages -Publisher
BMC
DOI: 10.1186/s13756-018-0313-5
Keywords
Acinetobacter Baumannii; Multidrug resistance; Polymyxin B; Ventriculitis; Intraventricular therapy
Ask authors/readers for more resources
Background: Acinetobacter baumannii nosocomial ventriculitis/meningitis, especially those due to drug-resistant strains, has substantially increased over recent years. However, limited therapeutic options exist for the Acinetobacter baumannii ventriculitis/meningitis because of the poor penetration rate of most antibiotics through the blood-brain barrier. Case presentation: A 57-year-old male patient developed ventriculitis from an extensively drug-resistant strain of Acinetobacter baumannii after the decompressive craniectomy for severe traumatic brain injury. The patient was successfully treated with intraventricular and intravenous polymyxin B together with intravenous tigecycline. Conclusions: The case illustrates intraventricular polymyxin B can be a therapeutic option against extensively drug-resistant Acinetobacter baumannii ventriculitis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available